2Patel D J, knight CJ, Holdright DR, et al. Pathophysiology of transient myoeardial isehemia in aeute eoronary syndromes. Cireulation, 1997,95 : 1185-1192.
3Jirim E. Effects of heparin treatment on collateral development and regional myocardial function in acute myocardial infarction .Am Heart J,1990.119(2ptl):248-251.
4Teleford. A, and Wilson C : Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndromes. Lancet, 1981,1:1225-1228.
5Theroux P. Oeiment H. and MeCanu, T:Aspirin. heparin or both to treat acute unstable angina .N Engl J Med, 1988,319:1105-1111.
6江明性主编．新编使用药物学．第1版．上海：科学出版社出版，2000．303—304．
7Fragmin during instabling in coronary artery disease (FRISC) study group. Low molecular weight heparin during instabling in coronary artery disease . Lancet, 1996,347 : 561-568.
3Braunw aid U mtable angina a classification C ircu lation, 1989,80(2):410.
4[1]Gurfinkel EP,Manos EJ,Mejail Rl,et al.Low molecular weight heparin versus regular heparn or aspirine in the treatment of unstable argina and silent ischemie[J].J Am Coil Cardiol,1995,26(2):313-318.
5[6]Vinazzer H.Advantages of low molecular weight heparin over standard:facts and fiction[J].Semin Thromb Hemost,1991,17(4):385-388.
